Loading company…
Reata Pharmaceuticals develops therapies for serious neurological and rare diseases.
Founded in 2002 and based in Plano, Texas, Reata Pharmaceuticals develops therapies for serious neurological and rare diseases. Its research targets cellular pathways linked to oxidative stress and inflammation, including conditions such as Friedreich's ataxia and Alport syndrome. In May 2016, it raised USD 287.70 million in a private placement and follow-on round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in